Scarica l'app Stockscreener
2.04
6.81%
0.13
Pre-mercato:
1.99
-0.05
-2.45%
Serina Therapeutics Inc Borsa (SER) Ultime notizie
Insider Buying: Karen Wilson Acquires Shares of Serina Therapeutics Inc (SER) - GuruFocus
Serina Therapeutics director Karen Wilson buys $17,749 common stock By Investing.com - Investing.com India
Serina Therapeutics director Karen Wilson buys $17,749 common stock - Investing.com UK
Director Karen J. Wilson boosts Serina (SER) stake with 10,100-share purchase - Stock Titan
Serina Therapeutics Inc. (SER) Q1 2026 Earnings: Losses Wider Than Expected as Pre-Revenue Biotech Continues Clinical DevelopmentFinal Results - newsline.com
Serina Therapeutics, Inc. Financial Disclosures & SEC Filings - TradingView
Serina Therapeutics (SER) Stock Price, News & Analysis $SER - MarketBeat
Serina Therapeutics (SER) Gains 4% as It Tests Key Resistance at $1.90BPI Bull Confirmed - newsline.com
Serina Therapeutics (SER) Tests Key Support After Modest DeclineDealer Delta - newsline.com
SER Q1 2026 Earnings: EPS Misses Estimates as Development-Focused Biotechnology Firm Continues Pipeline ProgressEarnings Revision Upgrade - newsline.com
SER News | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill
[EFFECT] Serina Therapeutics, Inc. SEC Filing - Stock Titan
Serina Therapeutics (SER) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Company Reports Wider Loss - thelegaladvocate.com
Serina Therapeutics Inc. Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Navigates Development CostsEarnings Volatility Report - The Legal Advocate
Serina Therapeutics (SER) stock surges over 39% after hours—here's why - MSN
Serina Therapeutics (SER) grants CEO 10,100 common shares - Stock Titan
Serina Therapeutics (SER) SVP granted 85,558 stock options at $1.89 - Stock Titan
Serina Therapeutics (SER) CEO awarded 380,825 stock options - Stock Titan
Serina Therapeutics (SER) CFO awarded 123,019 stock options at $1.89 - Stock Titan
Serina Therapeutics (SER) CSO receives 85,558 stock options at $1.89 strike - Stock Titan
Serina Therapeutics (SER) Faces Headwinds: Shares Decline 3% Toward Support at $1.82Break of Structure - The Legal Advocate
Serina Therapeutics director Karen Wilson buys $37,000 in shares By Investing.com - Investing.com India
Serina Therapeutics director Karen Wilson buys $37,000 in shares - Investing.com
Director boosts stake in Serina Therapeutics (SER) with 20K-share buy - Stock Titan
Serina Therapeutics (SER) Faces Selling Pressure, Tests Key Support LevelsMAMA Signal - thelegaladvocate.com
Serina Therapeutics (SER) Slips 6% as Stock Approaches Key Support LevelGap Down Bounce Plays - thelegaladvocate.com
Serina Therapeutics Inc (SER) Q1 2026 Earnings: EPS Miss Amid Continued Development ProgressFinancial Summary - Newser
Serina Therapeutics Q1 2026 Earnings: EPS Misses Estimates as Stock Climbs Despite LossGAAP Earnings Report - Newser
Serina Therapeutics Inc. (SER) Recovers 4.93% as Stock Approaches Key Resistance at $2.08Volume Spike Alerts - Newser
Serina Therapeutics Inc. (SER) Gains Nearly 5% as Stock Approaches Key ResistanceTop Analyst Buy Signals - Newser
Director at Serina Therapeutics (SER) makes open-market buy of 12,183 shares - Stock Titan
16.45M Serina shares registered for resale (NYSE: SER) - Stock Titan
Serina Therapeutics : Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed by Sobi - marketscreener.com
SER Stock Price, Quote & Chart | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill
Serina Therapeutics (SER) Gets a Buy from JonesTrading - The Globe and Mail
Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks - The Globe and Mail
Serina Therapeutics 1Q Loss/Shr 58c >SER - Moomoo
Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - The Manila Times
Parkinson's drug trial moves ahead as Serina adds $21.2M funding - Stock Titan
Serina Therapeutics (NYSE: SER) raises $21.2M and advances SER-252 trial - Stock Titan
Serina Therapeutics (NYSE: SER) posts Q1 loss and raises $21.2M PIPE amid cash risk - Stock Titan
SER Technical Analysis | Trend, Signals & Chart Patterns | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill
1.27%
1.43%
Capitalizzazione:
|
Volume (24 ore):